Last reviewed · How we verify

NCT05795426

An Investigation Of Kinesiophobia in Volleyball Players, With A Focus On Gender-Based Differences

Completed Last updated 17 November 2025
What this trial tests

trial in Volleyball Player in 52 participants. Completed in 20 September 2025.

Timeline
28 February 2025
Primary endpoint
6 March 2025
20 September 2025

Quick facts

Lead sponsorIstanbul Medipol University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date28 February 2025
Primary completion6 March 2025
Estimated completion20 September 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 18 to 25, male only, with Volleyball Player. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Kinesiophobia is a form of behavior that includes fear and anxiety in which the person tends to stay away from the movement. . In the future, this may lead to a decrease in muscle strength and condition, leading to loss or decrease in physical adequacy, avoidance of exercise and, accordingly, psychological problems. Kinesiophobia also negatively affects the success of the treatment process in athletes or normal patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05795426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing